Where are the adcomms? FDA has scheduled no drug or biologic meetings for 2024 so far
The FDA’s advisory committees of outside experts typically review controversial drug approval decisions at meetings scheduled months in advance. But the agency’s
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
